Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Econometric Views (EViews)01:29

Econometric Views (EViews)

Econometric Views, often stylized as EViews, is a package that merges statistical analysis with econometric studies. It is designed to provide tools for time series analysis, forecasting, and econometric model simulation. The software originated from MicroTSP software and has evolved significantly since its inception in 1981. The history of EViews is marked by a continuous effort to enhance its computational speed and user interface. It was initially developed for large computing systems but...
Social Exchange Theory01:26

Social Exchange Theory

As formulated by John Thibaut and Harold Kelley, Social Exchange Theory explains human relationships as economic-like exchanges that maximize rewards and minimize costs. This theory suggests that individuals engage in relationships to gain benefits and reduce burdens, similar to economic transactions. It has been widely applied to various types of relationships, including romantic, professional, and social interactions.Rewards and Costs in RelationshipsRelationship rewards include emotional...
Social Exchange Theory02:06

Social Exchange Theory

We have discussed why we form relationships, what attracts us to others, and different types of love. But what determines whether we are satisfied with and stay in a relationship? One theory that provides an explanation is social exchange theory. According to social exchange theory, we act as naïve economists in keeping a tally of the ratio of costs and benefits of forming and maintaining a relationship with others (Rusbult & Van Lange, 2003).
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple sclerosis treatment coverage: an analysis based on inequality indicators.

Revista de saude publica·2026
Same author

Challenges in resource allocation of diagnostic tests in Spain.

Expert review of pharmacoeconomics & outcomes research·2025
Same author

Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.

PharmacoEconomics·2023
Same author

Cost of lost productivity from acute respiratory infections in South America.

Revista panamericana de salud publica = Pan American journal of public health·2023
Same author

Tenders for generics and biosimilars: a challenging purchasing policy.

The European journal of health economics : HEPAC : health economics in prevention and care·2023
Same author

The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach.

Expert review of pharmacoeconomics & outcomes research·2023

Related Experiment Video

Updated: Jun 21, 2026

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
08:24

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies

Published on: August 25, 2023

Economic evaluations in the EURONHEED: a comparative analysis.

Florencia Hutter1, Fernando Antoñanzas

  • 1Department of Economics, Universidad de La Rioja, Logroño, Spain.

Pharmacoeconomics
|August 12, 2009
PubMed
Summary
This summary is machine-generated.

This review analyzed 346 European health economic evaluations (EEs) over 10 years. Significant country-based differences in methodology were found, highlighting a need for greater detail in health economic evaluations for result transferability.

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Related Experiment Videos

Last Updated: Jun 21, 2026

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
08:24

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies

Published on: August 25, 2023

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Area of Science:

  • Health Economics
  • Pharmacoeconomics
  • Evidence-Based Medicine

Background:

  • Economic evaluations (EEs) are crucial for healthcare decision-making.
  • Understanding methodological variations across European countries is essential for policy.
  • The European Network of Health Economics Evaluation Database (EURONHEED) provides a valuable resource for such analyses.

Purpose of the Study:

  • To review key methodological elements of published health EEs in Europe over the past decade.
  • To identify and compare methodological patterns of EEs across different European countries.
  • To assess the quality and transferability of health economic evidence.

Main Methods:

  • A systematic review of 346 economic evaluations from the EURONHEED database.
  • Analysis focused on interventions for bacterial/viral infections, and digestive/respiratory diseases.
  • Descriptive and bivariate statistical analyses were used to compare methodologies by country and publication year.

Main Results:

  • Approximately 50% of EEs focused on pharmacological interventions, with cost-effectiveness analysis being the most common.
  • Treatments were more frequently evaluated than diagnostic or preventive technologies, often from a health service perspective.
  • Significant country-specific differences were observed in EE types, study perspectives, and discounting practices, despite methodological improvements.

Conclusions:

  • Methodologies in European health economic evaluations show significant variation between countries.
  • While improvements are noted, some studies still lack essential elements for high-quality economic evaluations.
  • Detailed knowledge of methodologies across European countries is needed to improve the transferability of EE results.